Loading product
Loading product
Growth · Research material
Package information
For product inquiries and additional information, contact lonestarpeptideco@gmail.com.
Compliance notice: For laboratory research use only. Not for human or veterinary use.
Product information is intended for laboratory, academic and commercial researchers aged 18 or over.
Material profile
A 44-residue GHRH analogue modified at the N-terminus with a trans-3-hexenoyl group, which stabilises the peptide against dipeptidyl-peptidase cleavage in buffer. Supplied as a lyophilized powder at 20 mg in one vial. A box of 10 is available as an optional package. It is intended for cell-culture and analytical bench work. For laboratory research use only. Not for human or veterinary use.
Catalog record
| Product | Tesamorelin — 20 mg |
|---|---|
| Catalog SKU | TSM20 |
| Compound | Tesamorelin |
| Appearance | Lyophilized white powder |
| Fill per vial | 20 mg |
| Storage condition | -20 °C, desiccated, protect from light |
Laboratory handling
Delivered as a sealed lyophilized vial in an insulated cold-pack mailer. Long-term storage is at -20 degrees C in a desiccated, light-protected container. Once opened, the vial should be managed under the receiving laboratory's own SOPs for handling of lyophilized reference materials.
Evidence first
This listing does not currently publish lot-specific analytical results. Request and review the applicable documentation before using the material in laboratory work.
Published literature
Tesamorelin is a synthetic analog of the 44-amino acid human GHRH sequence, modified with a hexenoyl (trans-3-hexenoic acid) moiety anchored at the N-terminal tyrosine residue to improve stability relative to the native peptide. It functions as an agonist at the GHRH receptor, a class B G-protein-coupled receptor with seven membrane-spanning domains expressed on pituitary somatotrophs, signaling through Gs/cAMP pathways. Published population pharmacokinetic modeling characterizes tesamorelin disposition using a one-compartment model with first- and zero-order absorption and linear elimination. Tesamorelin is an approved prescription drug; this entry addresses only molecular structure, receptor pharmacology, and pharmacokinetics, and does not summarize body-composition or other clinical-trial outcome data.
Describes what the cited studies examined in the systems noted above — not a claim about outcomes for people. Not medical advice.
Product support
No downloadable certificate is currently attached to this listing. Email lonestarpeptideco@gmail.com if your laboratory requires lot-specific documentation for review.
Use the package selector to review the single-vial and box-of-10 formats, then use Email to inquire if you want to ask about that product.
The catalog storage condition is -20 °C, desiccated, protect from light. Follow the handling information on this page and your laboratory's written procedures.
No. It is presented only as laboratory research material and is not for human or veterinary use, food, drugs, cosmetics, household use, or self-administration.
Catalog navigation
Other catalog records grouped under the same editorial collection.
Lone Star Peptide Co.
10 mg
Product inquiries
Contact Lone Star Peptide Co. for product information and inquiries.
Email to inquireRequired notice
For laboratory research use only. Not for human or veterinary use, food, drugs, cosmetics, household use, or self-administration. Product information is provided for material identification, handling, and analytical documentation; it is not medical advice or a statement of clinical safety or effectiveness.
